<qa>  What is the protocol MSB-GVHD 001 of remestemcel-LOngoing safety assessment follow up to Protocol MSB-GVHD 001 of remestemcel-L treatment in pediatric subjects with acute Graft versus Host Disease aGVHD, following allogeneic hematopoietic stem cell transplant HSCT, that have failed to respond to treatment with systemic corticosteroid therapy. 